Medidata Solutions upgraded to Overweight from Neutral at Piper Jaffray Piper Jaffray upgraded Medidata Solutions citing the company's sustainable revenue growth and raised its price target for shares to $54 from $31.
News For MDSO From The Last 14 Days
Check below for free stories on MDSO the last two weeks.